SUED & FARGESA — Dapagliflozin Importer Profile
Pharmaceutical Importer · #17 buyer for Dapagliflozin · $592.5K import value · 19 shipments · DOMINICAN REPULIC · DGFT Verified
SUED & FARGESA is the #17 importer of Dapagliflozin from India with $592.5K in import value and 19 verified shipments. SUED & FARGESA holds a 1.5% market share in Dapagliflozin imports based in DOMINICAN REPULIC. The company sources from 1 verified supplier across 18 formulations shipped to 2 countries.
SUED & FARGESA — Dapagliflozin Import Profile: Suppliers, Formulations & Sources
Who Actually Supplies Dapagliflozin to SUED & FARGESA?
Verified from 19 customs shipment records
| Supplier | Value | Shipments | % Share |
|---|---|---|---|
| MICRO LABS LIMITED | $592.5K | 19 | 100.0% |
SUED & FARGESA sources Dapagliflozin from 1 verified Indian supplier based on 19 customs records. The primary supplier is MICRO LABS LIMITED accounting for 100.0% of imports.
How Does SUED & FARGESA Compare to Nearest Dapagliflozin Importers?
Buyers ranked immediately above and below #17 by import value
| # | Buyer | Country | Import Value | Shipments | Avg/Shipment |
|---|---|---|---|---|---|
| 11 | JAMP PHARMA CORPORATION. | CANADA | $750.0K | 15 | $50.0K |
| 16 | PHARMASCIENCE INC. | CANADA | $745.5K | 20 | $37.3K |
| 17 | SUED & FARGESA ★ | DOMINICAN REPUBLIC | $735.6K | 19 | $38.7K |
| 20 | PHARMASCIENCE INC | CANADA | $570.1K | 12 | $47.5K |
| 3 | MYLAN IRELAND LTD | NETHERLANDS | $500.0K | 10 | $50.0K |
SUED & FARGESA ranks #17 among 502 Dapagliflozin importers from India. Average shipment value of $38.7K compared to the market average of $33.1K. The closest competitors by value are JAMP PHARMA CORPORATION. and PHARMASCIENCE INC..
Where Does SUED & FARGESA Import Dapagliflozin To?
Destination countries from 19 verified shipments
| Country | Value | Shipments | Share |
|---|---|---|---|
| DOMINICAN REPULIC | $310.3K | 11 | 52.4% |
| DOMINICAN REPUBLIC | $282.2K | 8 | 47.6% |
SUED & FARGESA imports Dapagliflozin to 2 countries. The primary destination is DOMINICAN REPULIC receiving 52.4% of shipments worth $310.3K.
What Dapagliflozin Formulations Does SUED & FARGESA Import?
| Formulation | Value | Shipments |
|---|---|---|
| DAPAGLIP 10 ( (Dapagliflozin Tablets 10mg) ) ( 3X10S ) ( QTY- 11717.000 ) | $100.0K | 2 |
| DAPAGLIP 10MG (DAPAGLIFLOZIN TABLETS 10MG) (3X10'S) (QTY- 7720 ) TAX INV NO: 701209037/15.07.2024 | $50.0K | 1 |
| DAPAGLIP 10 (DAPAGLIFLOZIN TABLETS 10MG)(3X10`S)(QTY- 18156.000) TAX INV NO:701210053/07.04.2025 | $50.0K | 1 |
| DAPAGLIP M 10 / 1000 ( (Dapagliflozin 10mg+Extended Release Metformin HCL ) ( 3X10S ) ( QTY- 4562.000 ) | $43.3K | 1 |
| DAPAGLIP 10 (DAPAGLIFLOZIN TABLETS 10MG)(3X10'S) (QTY:5797) TAX INV NO:701208199/18.12.2023 | $42.3K | 1 |
| DAPAGLIP M 10/500(DAPAGLIFLOZIN 10MG+EXT | $33.7K | 1 |
| DAPAGLIP 10 ( (DAPAGLIFLOZIN TABLETS 10MG) ) ( 3X10S ) ( QTY- 4765.000 ) | $32.3K | 1 |
| DAPAGLIP M 5/500(DAPAGLIFLOZIN 5MG+EXTEN | $28.8K | 1 |
| DAPAGLIP 10 (Dapagliflozin Tablets 10mg) | $26.5K | 1 |
| DAPAGLIP 10MG(DAPAGLIFLOZIN TABLETS 10MG | $26.0K | 1 |
SUED & FARGESA imports 18 distinct Dapagliflozin formulations from India. The top formulation is DAPAGLIP 10 ( (Dapagliflozin Tablets 10mg) ) ( 3X10S ) ( QTY with 2 shipments worth $100.0K.
Who Are the Top Buyers of Dapagliflozin from India and How Much Does SUED & FARGESA Import?
India exported $16.6M worth of Dapagliflozin through 5,104 shipments from 254 suppliers to 113 countries, serving 502 buyers globally. SUED & FARGESA imports $592.5K of this total, accounting for 1.5% of India's Dapagliflozin exports with 19 shipments from DOMINICAN REPULIC. This is verified from 19 customs shipment records covering 18 distinct formulations.
What Is the Average Order Value for SUED & FARGESA's Dapagliflozin Imports?
SUED & FARGESA's average Dapagliflozin order value is $31.2K per consignment, based on 19 shipments totaling $592.5K. SUED & FARGESA is based in DOMINICAN REPULIC and ranks #17 among all Dapagliflozin importers from India by value. The company sources from 1 verified supplier in India.
Who Supplies Dapagliflozin to SUED & FARGESA?
SUED & FARGESA sources Dapagliflozin from 1 verified Indian supplier: MICRO LABS LIMITED ($592.5K, 100.0%). This is based on 19 customs records.
How Does SUED & FARGESA Compare to Other Dapagliflozin Importers?
SUED & FARGESA ranks #17 among 502 Dapagliflozin importers from India with a 1.5% market share. The top 3 importers are AWAMEDICA ($3.0M), JAMP PHARMA CORPORATION ($2.3M), REGENCY PHARMA LIMITED ($1.3M). SUED & FARGESA processed 19 shipments from DOMINICAN REPULIC.
Market Intelligence
Latest developments and market context
Detailed market intelligence for Dapagliflozin — including regulatory updates, trade policy changes, and competitive landscape analysis — will be available in an upcoming update. This section will feature AI-researched insights from verified industry sources, government notifications, and market reports.
Official References & Regulatory Resources
- European Medicines Agency
- WHO Essential Medicines
- Invest India — Pharma Sector
- India Trade Statistics (DGFT)
Verify import regulations and drug registration requirements with the agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Product Matching: Dapagliflozin shipments identified using fuzzy matching on DGFT product description fields, validated against Indian Pharmacopoeia nomenclature and HS code classification.
- 2.Buyer Identification: SUED & FARGESA matched across shipments using first-3-word normalization of the consignee field, accounting for company name formatting variations.
- 3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation. This removes the impact of unusually large one-off transactions that could distort buyer rankings.
- 4.Market Share: Calculated as SUED & FARGESA's capped import value divided by total capped export value for Dapagliflozin across all Indian exporters.
- 5.Verified Records: This page is backed by 19 individual customs records matching SUED & FARGESA importing Dapagliflozin, covering 18 formulations from 1 verified supplier.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
Global Coverage
Exports to 113+ countries, 502+ buyers
Expert-Reviewed
Analyzed by pharmaceutical trade specialists
Get Dapagliflozin Import Data for SUED & FARGESA
Access order-level details, pricing data, supplier connections, and competitive analysis for SUED & FARGESA's Dapagliflozin imports. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.
SUED & FARGESA
Company Profile
Multiple products · $0 total trade · Multiple categories
SUED & FARGESA × Dapagliflozin
Verified from customs records
Related Analysis
Need Detailed Import Data?
Access shipment-level records, supplier contacts, and formulation details for SUED & FARGESA.
Request DemoView Pricing →Data Source
Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. Market share calculated relative to total Indian pharmaceutical exports for Dapagliflozin. For current order-level data, contact TransData Nexus.